Related references
Note: Only part of the references are listed.Prospective Study of Bevacizumab Plus Temozolomide in Patients With Advanced Neuroendocrine Tumors
Jennifer A. Chan et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
First-Line Chemotherapy With Capecitabine and Temozolomide in Patients With Metastatic Pancreatic Endocrine Carcinomas
Jonathan R. Strosberg et al.
CANCER (2011)
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors.
Eric Raymond et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Everolimus for Advanced Pancreatic Neuroendocrine Tumors.
James C. Yao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
O-6-Methylguanine DNA Methyltransferase Deficiency and Response to Temozolomide-Based Therapy in Patients with Neuroendocrine Tumors
Matthew H. Kulke et al.
CLINICAL CANCER RESEARCH (2009)
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
Anja Rinke et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Multi-institutional phase II study of temozolomide administered twice daily in the treatment of recurrent high-grade gliomas
Casilda Balmaceda et al.
CANCER (2008)
One hundred years after Carcinoid: Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States
James C. Yao et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Activity of sunitinib in patients with advanced neuroendocrine tumors
Matthew H. Kulke et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Hepatic Neuroendocrine Metastases: Chemo- or Bland Embolization?
Susan C. Pitt et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2008)
Resection of pancreatic neuroendocrine tumors - Results of 70 cases
Kevork K. Kazanjian et al.
ARCHIVES OF SURGERY (2006)
Survival and response after peptide receptor radionuclide therapy with [90Y-DOTA0,Tyr3]octreotide in patients with advanced
R Valkema et al.
SEMINARS IN NUCLEAR MEDICINE (2006)
Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors
MH Kulke et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Molecular genetics of multiple endocrine neoplasia types 1 and 2
SJ Marx
NATURE REVIEWS CANCER (2005)
Partial hepatectomy for metastases from noncolorectal, nonneuroendocrine carcinoma
J Weitz et al.
ANNALS OF SURGERY (2005)
Multiple endocrine neoplasia - Introduction
SJ Marx et al.
JOURNAL OF INTERNAL MEDICINE (2005)
Small-cell carcinomas of the gastrointestinal tract: A review
B Brenner et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system
K Öberg et al.
ANNALS OF ONCOLOGY (2004)
Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome - A prospective study of 107 cases and comparison with 1009 cases from the literature
F Gibril et al.
MEDICINE (2004)
Lack of efficacy of streptozocin and doxorubicin in patients with advanced pancreatic endocrine tumors
AD McCollum et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2004)
Interest of Chromogranin A for diagnosis and follow-up of endocrine tumours
D Nehar et al.
CLINICAL ENDOCRINOLOGY (2004)
Treatment of neuroendocrine tumours with infusional 5-fluorouracil, folinic acid and streptozocin
MA Gonzalez et al.
BRITISH JOURNAL OF CANCER (2003)
Efficacy of a chemotherapy combination for the treatment of metastatic neuroendocrine tumours
E Bajetta et al.
ANNALS OF ONCOLOGY (2002)
Guidelines for diagnosis and therapy of MEN type 1 and type 2
ML Brandi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Phase II trial of dacarbazine (DTIC) in advanced pancreatic islet cell carcinoma. Study of the Eastern Cooperative Oncology Group-E6282
RK Ramanathan et al.
ANNALS OF ONCOLOGY (2001)
Antitumour activity of somatostatin analogues in progressive metastatic neuroendocrine tumours
T Aparicio et al.
EUROPEAN JOURNAL OF CANCER (2001)
Share Paper
